Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
Recent update in the management of chronic obstructive pulmonary disease – an Asian perspective30 October, 2019Dr Diahn-Warng Perng, MD, PhD Professor, School of Medicine, National Yang-Ming University Chief, Clinical Respiratory Physiology, Department of Chest Medicine Taipei Veterans General... -
Cigarette smoking enhances MRSA11 October, 2019New evidence from scientists at the University of Bath suggests that the ability of the superbug, methicillin-resistant Staphylococcus aureus (MRSA), to resist antibiotics is enhanced by the... -
Beneficial short-course antibiotic for pneumonia – A call for awareness8 September, 2019More than two-thirds of patients hospitalised with pneumonia were prescribed with excess duration of antibiotic therapy, reports a retrospective cohort study conducted in 43 hospitals in... -
Respiratory syncytial virus (RSV) – not bacteria – a leading cause of childhood pneumonia2 August, 2019Researchers of the Pneumonia Etiology Research for Child Health (PERCH) study reported that viruses are the leading cause of severe pneumonia in children younger than five years without human... -
Previously unknown bacterial communities responsible for recurrent urinary tract infections in postmenopausal women9 July, 2019Researchers at The University of Texas (UT) at Dallas and UT Southwestern Medical Center have identified several species of bacteria that form bacterial communities responsible for recurrent... -
Superbugs found on patients’ hands at the start of hospitalisation9 June, 2019The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) have been advocating for hand hygiene as an important tool in infection control within healthcare... -
Levofloxacin: High-dose, short-course for bacterial infection28 April, 2019Associate Professor Panpit Suwangool Bangkok Hospital, Thailand Levofloxacin is a well-established antibacterial for respiratory and urinary tract infections.1 Levofloxacin is active against... -
Oral sitafloxacin vs intravenous ceftriaxone for the treatment of acute pyelonephritis and complicated urinary tract infection9 April, 2019An open-label randomised, controlled, noninferiority clinical trial has shown that oral sitafloxacin is noninferior to intravenous (IV) ceftriaxone followed by oral cefdinir for the treatment of... -
Levofloxacin remains as one of the core agents in the treatment of tuberculosis2 April, 2019According to the current World Health Organization (WHO) guidelines (2016 update), fluoroquinolones including moxifloxacin, gatifloxacin, and levofloxacin are important second-line... -
First malaria saliva test identifies malaria parasites20 March, 2019Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Recent update in the management of chronic obstructive pulmonary disease – an Asian perspective -
Levofloxacin: High-dose, short-course for bacterial infection -
2018 Taiwan’s pneumonia guidelines: What’s new? -
Interview with Prof Wang Minggui -
Levofloxacin for the Management of Hospital-Acquired, Ventilator-Associated and Healthcare-Associated Pneumonia (Interview with Prof. Marin H. Kollef) -
The Use of Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (Interview with Prof. Hartmut Lode) -
Effect of Combination of Levofloxacin and Meropenem against Pseudomonas aeruginosa (Supervised by Prof. Kazuhiro Tateda, MD, PhD) -
Viewing Infectious Respiratory Disease (Supervised by Prof. Jiro Fujita, MD, PhD, ACCP) -
New Challenges for Levofloxacin in the Fight Against Infectious Diseases (Interviews with World-Renowned Experts) -
New Era for the Treatment of Respiratory Tract infections (Daiichi Pharmaceutical Co., Ltd., Special Interview)